Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Radiotheranostics Market to reach USD 20.67 billion by the end of 2030.

Global Radiotheranostics Market Size study & Forecast, by Radioisotope (Iodine-131, Iodine-123, Gallium-68, Lutetium-177, 18F with Y-90, Others), by Approach (Targeted Therapeutic, Targeted Diagnostic), by Application (Oncology, Non Oncology) by and Regional Analysis, 2023-2030

Product Code: HLSMD-46583290
Publish Date: 19-06-2023
Page: 200

Global Radiotheranostics Market is valued at approximately USD 7.51 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 13.49% over the forecast period 2023-2030. Radiotheranostics refers to the field of medicine that combine the therapeutic and diagnostic application of radiopharmaceuticals enabling personalized treatment strategies by using targeted radiation therapy and imaging techniques. The Radiotheranostics market is being driven by factors such as the Increasing prevalence of cancer cases and the rising adoption of injectable radiopharmaceuticals.
Radiotheranostics offers a personalized and targeted approach to cancer management. By combining diagnostic imaging with therapeutic interventions, it enhances precision, improves treatment outcomes, reduces side effects, and enables personalized therapies based on individual patients’ characteristics and disease biology.According to the International Agency for Research on Cancer, Worldwide, an estimated 17 million new cancer cases in 2018 and it is estimated to rise by 27.5 million new cancer cases in 2040. Thus, rising in cancer cases fueling the market growth. In addition, increasing the approvals of new radiotheranostics agents and increasing public-private funding for research may create lucrative opportunities for the market. However, market expansion may hinder due to the high cost involved in research and development.

The key regions considered for the Global RadiotheranosticsMarket study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America holds the major share in radio theranostics market due to the rising overweight population and also rising adoption of large number of market players. Asia Pacific consider fastest growing market due to its large patient base and high investing nuclear medicine along with that rising orevlance of cancer.

Major market player included in this report are:
Novartis AG
Bayer AG
Progenics Pharmaceuticals, Inc.( Lantheus)
Telix Pharmaceuticals Limited.
ITM Isotope Technologies Munich SE
Life Molecular Imaging.
RadioMedix Inc.
IsoTherapeutics Group, LLC
Q BioMed Inc.
Nordic Nanovector ASA

Recent Developments in the Market:
• On May 2022, Transcode therapeutics Inc. announced the execution of an option agreement under which transcode will have the right to negotiate an exclusive, world, royalty-bearing licence for a radiotheranostic technology disclosed in patent application PCT/US2021/057912 Entitled THERAPEUTICS, RADIOLABLED NANOPARTICLES AND METHOD OF USE THEREOF.
• On Oct 2022, Clarity pharmaceuticals announced that the first patient in its phase1/2theranostic trial, which is testing 64Cu/67Cu SAR-bisPSMA theranostic product in people with metastatic castrate-restant prostate cancer, has been given a dose. The promising preclinical and clinical result so far support clarity’s investigation of the optimised SAR-bisPSMA product in additional oncology indications where the theranostic approach may be useful.

Global RadiotheranosticsMarket Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Radioisotope, Approach, Application, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Radioisotope:
Iodine-131
Iodine-123
Gallium-68
Lutetium-177
18F with Y-90
Others

By Approach:
Targeted Therapeutic
Targeted Diagnostic

Application:
Oncology
Non Oncology

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Radiotheranostics Market, by Region, 2020-2030 (USD Billion)
1.2.2. Radiotheranostics Market, by Radioisotope, 2020-2030 (USD Billion)
1.2.3. Radiotheranostics Market, by Approach, 2020-2030 (USD Billion)
1.2.4. Radiotheranostics Market, by Application, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Radiotheranostics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Radiotheranostics Market Dynamics
3.1. Radiotheranostics Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing prevalence of cancer cases.
3.1.1.2. Rising adoption of injectable radiopharmaceuticals.
3.1.2. Market Challenges
3.1.2.1. High cost involved in research and development.
3.1.3. Market Opportunities
3.1.3.1. Increasing the approvals of new radiotheranostics agents.
3.1.3.2. Increasing public-private funding for research and development.
Chapter 4. Global Radiotheranostics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Radiotheranostics Market, by Radioisotope
5.1. Market Snapshot
5.2. Global Radiotheranostics Market by Radioisotope, Performance – Potential Analysis
5.3. Global Radiotheranostics Market Estimates & Forecasts by Radioisotope 2020-2030 (USD Billion)
5.4. Radiotheranostics Market, Sub Segment Analysis
5.4.1. Iodine-131
5.4.2. Iodine-123
5.4.3. Gallium-68
5.4.4. Lutetium-177
5.4.5. 18F with Y-90
5.4.6. Others
Chapter 6. Global Radiotheranostics Market, by Approach
6.1. Market Snapshot
6.2. Global Radiotheranostics Market by Approach, Performance – Potential Analysis
6.3. Global Radiotheranostics Market Estimates & Forecasts by Approach 2020-2030 (USD Billion)
6.4. Radiotheranostics Market, Sub Segment Analysis
6.4.1. Targeted therapeutic
6.4.2. Targeted Diagnostic
Chapter 7. Global Radiotheranostics Market, by Application
7.1. Market Snapshot
7.2. Global Radiotheranostics Market by Application, Performance – Potential Analysis
7.3. Global Radiotheranostics Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
7.4. Radiotheranostics Market, Sub Segment Analysis
7.4.1. Oncology
7.4.2. Non-oncology
Chapter 8. Global Radiotheranostics Market, Regional Analysis
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Radiotheranostics Market, Regional Market Snapshot
8.4. North America Radiotheranostics Market
8.4.1. U.S. Radiotheranostics Market
8.4.1.1. Radioisotope breakdown estimates & forecasts, 2020-2030
8.4.1.2. Approach breakdown estimates & forecasts, 2020-2030
8.4.1.3. Application breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Radiotheranostics Market
8.5. Europe Radiotheranostics Market Snapshot
8.5.1. U.K. Radiotheranostics Market
8.5.2. Germany Radiotheranostics Market
8.5.3. France Radiotheranostics Market
8.5.4. Spain Radiotheranostics Market
8.5.5. Italy Radiotheranostics Market
8.5.6. Rest of Europe Radiotheranostics Market
8.6. Asia-Pacific Radiotheranostics Market Snapshot
8.6.1. China Radiotheranostics Market
8.6.2. India Radiotheranostics Market
8.6.3. Japan Radiotheranostics Market
8.6.4. Australia Radiotheranostics Market
8.6.5. South Korea Radiotheranostics Market
8.6.6. Rest of Asia Pacific Radiotheranostics Market
8.7. Latin America Radiotheranostics Market Snapshot
8.7.1. Brazil Radiotheranostics Market
8.7.2. Mexico Radiotheranostics Market
8.8. Middle East & Africa Radiotheranostics Market
8.8.1. Saudi Arabia Radiotheranostics Market
8.8.2. South Africa Radiotheranostics Market
8.8.3. Rest of Middle East & Africa Radiotheranostics Market

Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Novartis AG
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Bayer AG
9.3.3. Progenics Pharmaceuticals Inc.
9.3.4. Telix Pharmaceuticals
9.3.5. ITM Isotope Technologies Munich SE
9.3.6. Life molecular imaging
9.3.7. Radiomedix Inc.
9.3.8. Iso Therapeutics Group,LLC
9.3.9. Q Bio med Inc.
9.3.10. Nordic nanovector ASA
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now